Partner David Simon was interviewed by The FCPA Report (11/20/2013) on effective techniques for conducting anti-corruption risk assessments. With “no government-promulgated method for conducting a sufficient anti-corruption risk assessment,” the article explains, “the risk profile of every company is different.” When asked the goal of performing a periodic anti-corruption assessment, David noted three particular goals: 1. Identify problem areas; 2) “raise issues the company may not be aware of;” and 3) meet the expectation of regulators.
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."